SPOTLIGHT -
Dr. Randall on Emerging Treatment Strategies in Cervical Cancer
Leslie M. Randall, MD, associate professor, Division of Gynecologic Oncology, UC Irvine Health, discusses emerging treatment strategies in the treatment of patients with cervical cancer.
Read More
Dr. Randall on Next Steps With PARP Inhibitors in Gynecologic Malignancies
Leslie M. Randall, MD, associate professor, Division of Gynecologic Oncology, UC Irvine Health, discusses next steps with PARP inhibitors in the treatment of patients with gynecologic malignancies.
Dr. Leslie M. Randall on Early BRCA Testing in Ovarian Cancer
Dr. Leslie Randall Discusses Evidence Supporting BRCA Testing in Ovarian Cancer
Leslie M. Randall, MD, associate professor of Gynecology/ Oncology, University of California Irvine, discusses evidence supporting the use of BRCA testing for patients with ovarian cancer.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)